<!DOCTYPE html>
<html lang="en-US"
	prefix="og: https://ogp.me/ns#" >
<head>
<meta charset="UTF-8">
<meta name="viewport" content="width=device-width, initial-scale=1">
<link rel="profile" href="http://gmpg.org/xfn/11">
<link rel="pingback" href="http://trials.hematology.tw/xmlrpc.php">

<title>NCKUH Hema Trials Dashboard - NCKUH Hema Trials</title>

		<!-- All in One SEO 4.1.6.2 -->
		<meta name="description" content="Leukemia 臨床試驗列表 試驗名稱 診斷 條件 機轉 年齡 類型 試驗組 對照組 預計收案 已收案 篩選失敗 剩餘名額 SN MK-1026-011 CLL/SLL Untreated BTK inhibitor ≥20 years III Nemtabrutinib ibrutina/acalatinib 7 6 1 2 李佳玲/4620 BGB-16673-303 CLL/SLL Relapsed/Refractory CLL/SLL (Exposed to Covalent BTK Inhibitors) BTK-targeting chimeric degradation activation compound (CDAC) ≥18 years III Catadegbrutinib (BGB-16673) BR / high-dose methylprednisolone + […]" />
		<meta name="robots" content="max-image-preview:large" />
		<link rel="canonical" href="http://trials.hematology.tw/" />
		<meta property="og:locale" content="en_US" />
		<meta property="og:site_name" content="NCKUH Hema Trials -" />
		<meta property="og:type" content="article" />
		<meta property="og:title" content="NCKUH Hema Trials Dashboard - NCKUH Hema Trials" />
		<meta property="og:description" content="Leukemia 臨床試驗列表 試驗名稱 診斷 條件 機轉 年齡 類型 試驗組 對照組 預計收案 已收案 篩選失敗 剩餘名額 SN MK-1026-011 CLL/SLL Untreated BTK inhibitor ≥20 years III Nemtabrutinib ibrutina/acalatinib 7 6 1 2 李佳玲/4620 BGB-16673-303 CLL/SLL Relapsed/Refractory CLL/SLL (Exposed to Covalent BTK Inhibitors) BTK-targeting chimeric degradation activation compound (CDAC) ≥18 years III Catadegbrutinib (BGB-16673) BR / high-dose methylprednisolone + […]" />
		<meta property="og:url" content="http://trials.hematology.tw/" />
		<meta property="article:published_time" content="2021-04-15T00:02:21+00:00" />
		<meta property="article:modified_time" content="2026-01-26T04:47:12+00:00" />
		<meta name="twitter:card" content="summary" />
		<meta name="twitter:title" content="NCKUH Hema Trials Dashboard - NCKUH Hema Trials" />
		<meta name="twitter:description" content="Leukemia 臨床試驗列表 試驗名稱 診斷 條件 機轉 年齡 類型 試驗組 對照組 預計收案 已收案 篩選失敗 剩餘名額 SN MK-1026-011 CLL/SLL Untreated BTK inhibitor ≥20 years III Nemtabrutinib ibrutina/acalatinib 7 6 1 2 李佳玲/4620 BGB-16673-303 CLL/SLL Relapsed/Refractory CLL/SLL (Exposed to Covalent BTK Inhibitors) BTK-targeting chimeric degradation activation compound (CDAC) ≥18 years III Catadegbrutinib (BGB-16673) BR / high-dose methylprednisolone + […]" />
		<script type="application/ld+json" class="aioseo-schema">
			{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebSite","@id":"http:\/\/trials.hematology.tw\/#website","url":"http:\/\/trials.hematology.tw\/","name":"NCKUH Hema Trials","inLanguage":"en-US","publisher":{"@id":"http:\/\/trials.hematology.tw\/#person"},"potentialAction":{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"http:\/\/trials.hematology.tw\/?s={search_term_string}"},"query-input":"required name=search_term_string"}},{"@type":"BreadcrumbList","@id":"http:\/\/trials.hematology.tw\/#breadcrumblist","itemListElement":[{"@type":"ListItem","@id":"http:\/\/trials.hematology.tw\/#listItem","position":1,"item":{"@type":"WebPage","@id":"http:\/\/trials.hematology.tw\/","name":"Home","description":"Leukemia \u81e8\u5e8a\u8a66\u9a57\u5217\u8868 \u8a66\u9a57\u540d\u7a31 \u8a3a\u65b7 \u689d\u4ef6 \u6a5f\u8f49 \u5e74\u9f61 \u985e\u578b \u8a66\u9a57\u7d44 \u5c0d\u7167\u7d44 \u9810\u8a08\u6536\u6848 \u5df2\u6536\u6848 \u7be9\u9078\u5931\u6557 \u5269\u9918\u540d\u984d SN MK-1026-011 CLL\/SLL Untreated BTK inhibitor \u226520 years III Nemtabrutinib ibrutina\/acalatinib 7 6 1 2 \u674e\u4f73\u73b2\/4620 BGB-16673-303 CLL\/SLL Relapsed\/Refractory CLL\/SLL (Exposed to Covalent BTK Inhibitors) BTK-targeting chimeric degradation activation compound (CDAC) \u226518 years III Catadegbrutinib (BGB-16673) BR \/ high-dose methylprednisolone + [\u2026]","url":"http:\/\/trials.hematology.tw\/"}}]},{"@type":"WebPage","@id":"http:\/\/trials.hematology.tw\/#webpage","url":"http:\/\/trials.hematology.tw\/","name":"NCKUH Hema Trials Dashboard - NCKUH Hema Trials","description":"Leukemia \u81e8\u5e8a\u8a66\u9a57\u5217\u8868 \u8a66\u9a57\u540d\u7a31 \u8a3a\u65b7 \u689d\u4ef6 \u6a5f\u8f49 \u5e74\u9f61 \u985e\u578b \u8a66\u9a57\u7d44 \u5c0d\u7167\u7d44 \u9810\u8a08\u6536\u6848 \u5df2\u6536\u6848 \u7be9\u9078\u5931\u6557 \u5269\u9918\u540d\u984d SN MK-1026-011 CLL\/SLL Untreated BTK inhibitor \u226520 years III Nemtabrutinib ibrutina\/acalatinib 7 6 1 2 \u674e\u4f73\u73b2\/4620 BGB-16673-303 CLL\/SLL Relapsed\/Refractory CLL\/SLL (Exposed to Covalent BTK Inhibitors) BTK-targeting chimeric degradation activation compound (CDAC) \u226518 years III Catadegbrutinib (BGB-16673) BR \/ high-dose methylprednisolone + [\u2026]","inLanguage":"en-US","isPartOf":{"@id":"http:\/\/trials.hematology.tw\/#website"},"breadcrumb":{"@id":"http:\/\/trials.hematology.tw\/#breadcrumblist"},"datePublished":"2021-04-15T00:02:21+08:00","dateModified":"2026-01-26T04:47:12+08:00"}]}
		</script>
		<!-- All in One SEO -->

<link rel='dns-prefetch' href='//cdn.datatables.net' />
<link rel='dns-prefetch' href='//cdnjs.cloudflare.com' />
<link rel='dns-prefetch' href='//www.google.com' />
<link rel='dns-prefetch' href='//fonts.googleapis.com' />
<link rel='dns-prefetch' href='//s.w.org' />
<link rel="alternate" type="application/rss+xml" title="NCKUH Hema Trials &raquo; Feed" href="http://trials.hematology.tw/feed/" />
<link rel="alternate" type="application/rss+xml" title="NCKUH Hema Trials &raquo; Comments Feed" href="http://trials.hematology.tw/comments/feed/" />
		<!-- This site uses the Google Analytics by MonsterInsights plugin v10.0.1 - Using Analytics tracking - https://www.monsterinsights.com/ -->
		<!-- Note: MonsterInsights is not currently configured on this site. The site owner needs to authenticate with Google Analytics in the MonsterInsights settings panel. -->
					<!-- No tracking code set -->
				<!-- / Google Analytics by MonsterInsights -->
				<script type="text/javascript">
			window._wpemojiSettings = {"baseUrl":"https:\/\/s.w.org\/images\/core\/emoji\/13.0.1\/72x72\/","ext":".png","svgUrl":"https:\/\/s.w.org\/images\/core\/emoji\/13.0.1\/svg\/","svgExt":".svg","source":{"concatemoji":"http:\/\/trials.hematology.tw\/wp-includes\/js\/wp-emoji-release.min.js?ver=5.7.14"}};
			!function(e,a,t){var n,r,o,i=a.createElement("canvas"),p=i.getContext&&i.getContext("2d");function s(e,t){var a=String.fromCharCode;p.clearRect(0,0,i.width,i.height),p.fillText(a.apply(this,e),0,0);e=i.toDataURL();return p.clearRect(0,0,i.width,i.height),p.fillText(a.apply(this,t),0,0),e===i.toDataURL()}function c(e){var t=a.createElement("script");t.src=e,t.defer=t.type="text/javascript",a.getElementsByTagName("head")[0].appendChild(t)}for(o=Array("flag","emoji"),t.supports={everything:!0,everythingExceptFlag:!0},r=0;r<o.length;r++)t.supports[o[r]]=function(e){if(!p||!p.fillText)return!1;switch(p.textBaseline="top",p.font="600 32px Arial",e){case"flag":return s([127987,65039,8205,9895,65039],[127987,65039,8203,9895,65039])?!1:!s([55356,56826,55356,56819],[55356,56826,8203,55356,56819])&&!s([55356,57332,56128,56423,56128,56418,56128,56421,56128,56430,56128,56423,56128,56447],[55356,57332,8203,56128,56423,8203,56128,56418,8203,56128,56421,8203,56128,56430,8203,56128,56423,8203,56128,56447]);case"emoji":return!s([55357,56424,8205,55356,57212],[55357,56424,8203,55356,57212])}return!1}(o[r]),t.supports.everything=t.supports.everything&&t.supports[o[r]],"flag"!==o[r]&&(t.supports.everythingExceptFlag=t.supports.everythingExceptFlag&&t.supports[o[r]]);t.supports.everythingExceptFlag=t.supports.everythingExceptFlag&&!t.supports.flag,t.DOMReady=!1,t.readyCallback=function(){t.DOMReady=!0},t.supports.everything||(n=function(){t.readyCallback()},a.addEventListener?(a.addEventListener("DOMContentLoaded",n,!1),e.addEventListener("load",n,!1)):(e.attachEvent("onload",n),a.attachEvent("onreadystatechange",function(){"complete"===a.readyState&&t.readyCallback()})),(n=t.source||{}).concatemoji?c(n.concatemoji):n.wpemoji&&n.twemoji&&(c(n.twemoji),c(n.wpemoji)))}(window,document,window._wpemojiSettings);
		</script>
		<style type="text/css">
img.wp-smiley,
img.emoji {
	display: inline !important;
	border: none !important;
	box-shadow: none !important;
	height: 1em !important;
	width: 1em !important;
	margin: 0 .07em !important;
	vertical-align: -0.1em !important;
	background: none !important;
	padding: 0 !important;
}
</style>
	<link rel='stylesheet' id='litespeed-cache-dummy-css'  href='http://trials.hematology.tw/wp-content/plugins/litespeed-cache/assets/css/litespeed-dummy.css?ver=5.7.14' type='text/css' media='all' />
<link rel='stylesheet' id='wp-block-library-css'  href='http://trials.hematology.tw/wp-includes/css/dist/block-library/style.min.css?ver=5.7.14' type='text/css' media='all' />
<link rel='stylesheet' id='wp2s2fg-fetcher-style-css'  href='http://trials.hematology.tw/wp-content/plugins/wp-simple-spreadsheet-fetcher-for-google/src/assets/css/style.css?ver=5.7.14' type='text/css' media='all' />
<link rel='stylesheet' id='jquery-datatables-css'  href='https://cdn.datatables.net/1.10.20/css/jquery.dataTables.min.css?ver=5.7.14' type='text/css' media='all' />
<link rel='stylesheet' id='datatables-buttons-css'  href='https://cdn.datatables.net/buttons/1.6.1/css/buttons.dataTables.min.css?ver=5.7.14' type='text/css' media='all' />
<link rel='stylesheet' id='datatables-select-css'  href='https://cdn.datatables.net/select/1.3.1/css/select.dataTables.min.css?ver=5.7.14' type='text/css' media='all' />
<link rel='stylesheet' id='datatables-fixedheader-css'  href='https://cdn.datatables.net/fixedheader/3.1.6/css/fixedHeader.dataTables.min.css?ver=5.7.14' type='text/css' media='all' />
<link rel='stylesheet' id='datatables-fixedcolumns-css'  href='https://cdn.datatables.net/fixedcolumns/3.3.0/css/fixedColumns.dataTables.min.css?ver=5.7.14' type='text/css' media='all' />
<link rel='stylesheet' id='datatables-responsive-css'  href='https://cdn.datatables.net/responsive/2.2.3/css/responsive.dataTables.min.css?ver=5.7.14' type='text/css' media='all' />
<link rel='stylesheet' id='flatter-google-fonts-css'  href='http://fonts.googleapis.com/css?family=Open+Sans%3A300italic%2C400italic%2C700italic%2C400%2C700%2C300&#038;ver=5.7.14' type='text/css' media='all' />
<link rel='stylesheet' id='flatter-style-css'  href='http://trials.hematology.tw/wp-content/themes/flatter/style.css?ver=5.7.14' type='text/css' media='all' />
<link rel='stylesheet' id='bootstrap-css'  href='http://trials.hematology.tw/wp-content/themes/flatter/css/bootstrap.css?ver=5.7.14' type='text/css' media='all' />
<link rel='stylesheet' id='font-awesome-css'  href='http://trials.hematology.tw/wp-content/themes/flatter/css/font-awesome.css?ver=5.7.14' type='text/css' media='all' />
<link rel='stylesheet' id='animate-min-css'  href='http://trials.hematology.tw/wp-content/themes/flatter/css/animate.css?ver=5.7.14' type='text/css' media='all' />
<link rel='stylesheet' id='owl-carousel-css'  href='http://trials.hematology.tw/wp-content/themes/flatter/css/owl.carousel.css?ver=5.7.14' type='text/css' media='all' />
<link rel='stylesheet' id='owl-theme-css'  href='http://trials.hematology.tw/wp-content/themes/flatter/css/owl.theme.css?ver=5.7.14' type='text/css' media='all' />
<link rel='stylesheet' id='flatter-main-css'  href='http://trials.hematology.tw/wp-content/themes/flatter/css/main.css?ver=5.7.14' type='text/css' media='all' />
<link rel='stylesheet' id='flatter-responsive-css'  href='http://trials.hematology.tw/wp-content/themes/flatter/css/responsive.css?ver=5.7.14' type='text/css' media='all' />
<script type='text/javascript' src='http://trials.hematology.tw/wp-includes/js/jquery/jquery.min.js?ver=3.5.1' id='jquery-core-js'></script>
<script type='text/javascript' src='http://trials.hematology.tw/wp-includes/js/jquery/jquery-migrate.min.js?ver=3.3.2' id='jquery-migrate-js'></script>
<script type='text/javascript' src='https://cdn.datatables.net/1.10.20/js/jquery.dataTables.min.js?ver=5.7.14' id='jquery-datatables-js'></script>
<script type='text/javascript' src='https://cdn.datatables.net/buttons/1.6.1/js/dataTables.buttons.min.js?ver=5.7.14' id='datatables-buttons-js'></script>
<script type='text/javascript' src='//cdn.datatables.net/buttons/1.6.1/js/buttons.colVis.min.js?ver=5.7.14' id='datatables-buttons-colvis-js'></script>
<script type='text/javascript' src='//cdn.datatables.net/buttons/1.6.1/js/buttons.print.min.js?ver=5.7.14' id='datatables-buttons-print-js'></script>
<script type='text/javascript' src='//cdnjs.cloudflare.com/ajax/libs/pdfmake/0.1.53/pdfmake.min.js?ver=5.7.14' id='pdfmake-js'></script>
<script type='text/javascript' src='//cdnjs.cloudflare.com/ajax/libs/pdfmake/0.1.53/vfs_fonts.js?ver=5.7.14' id='pdfmake-fonts-js'></script>
<script type='text/javascript' src='//cdnjs.cloudflare.com/ajax/libs/jszip/3.1.3/jszip.min.js?ver=5.7.14' id='jszip-js'></script>
<script type='text/javascript' src='//cdn.datatables.net/buttons/1.6.1/js/buttons.html5.min.js?ver=5.7.14' id='datatables-buttons-html5-js'></script>
<script type='text/javascript' src='https://cdn.datatables.net/select/1.3.1/js/dataTables.select.min.js?ver=5.7.14' id='datatables-select-js'></script>
<script type='text/javascript' src='https://cdn.datatables.net/fixedheader/3.1.6/js/dataTables.fixedHeader.min.js?ver=5.7.14' id='datatables-fixedheader-js'></script>
<script type='text/javascript' src='https://cdn.datatables.net/fixedcolumns/3.3.0/js/dataTables.fixedColumns.min.js?ver=5.7.14' id='datatables-fixedcolumns-js'></script>
<script type='text/javascript' src='https://cdn.datatables.net/responsive/2.2.3/js/dataTables.responsive.min.js?ver=5.7.14' id='datatables-responsive-js'></script>
<script type='text/javascript' id='igsv-datatables-js-extra'>
/* <![CDATA[ */
var igsv_plugin_vars = {"lang_dir":"http:\/\/trials.hematology.tw\/wp-content\/plugins\/inline-google-spreadsheet-viewer\/languages","datatables_classes":".igsv-table:not(.no-datatables)","datatables_defaults_object":{"dom":"B<'clear'>lfrtip","buttons":["colvis","copy","csv","excel","pdf","print"]}};
/* ]]> */
</script>
<script type='text/javascript' src='http://trials.hematology.tw/wp-content/plugins/inline-google-spreadsheet-viewer/igsv-datatables.js?ver=5.7.14' id='igsv-datatables-js'></script>
<script type='text/javascript' src='//www.google.com/jsapi?ver=5.7.14' id='google-ajax-api-js'></script>
<script type='text/javascript' src='http://trials.hematology.tw/wp-content/plugins/inline-google-spreadsheet-viewer/igsv-gvizcharts.js?ver=5.7.14' id='igsv-gvizcharts-js'></script>
<script type='text/javascript' src='http://trials.hematology.tw/wp-content/plugins/wp-simple-spreadsheet-fetcher-for-google/src/blocks/fetcher-chart/googleChart.js?ver=1.0.0' id='google-charts-js'></script>
<link rel="https://api.w.org/" href="http://trials.hematology.tw/wp-json/" /><link rel="alternate" type="application/json" href="http://trials.hematology.tw/wp-json/wp/v2/pages/28" /><link rel="EditURI" type="application/rsd+xml" title="RSD" href="http://trials.hematology.tw/xmlrpc.php?rsd" />
<link rel="wlwmanifest" type="application/wlwmanifest+xml" href="http://trials.hematology.tw/wp-includes/wlwmanifest.xml" /> 
<meta name="generator" content="WordPress 5.7.14" />
<link rel='shortlink' href='http://trials.hematology.tw/' />
<link rel="alternate" type="application/json+oembed" href="http://trials.hematology.tw/wp-json/oembed/1.0/embed?url=http%3A%2F%2Ftrials.hematology.tw%2F" />
<link rel="alternate" type="text/xml+oembed" href="http://trials.hematology.tw/wp-json/oembed/1.0/embed?url=http%3A%2F%2Ftrials.hematology.tw%2F&#038;format=xml" />
<script>var wssffg_rest_url = "http://trials.hematology.tw/wp-json/";</script>
	<style type="text/css" id="custom-background-css">
body.custom-background { background-color: #b1b9bf; }
</style>
	
</head>

<body class="home page-template page-template-fullwidth page-template-fullwidth-php page page-id-28 custom-background">
	<section class="logo-menu">
	<div class="container">		
		<div class="row">
			<div class="col-sm-3">
				<div class="logo">
          			                        <h1><a href="http://trials.hematology.tw/" rel="home">NCKUH Hema Trials</a></h1>                            
                                        <h6 class="slogon"></h6>
      			</div>
    		</div> <!-- /.end of col-sm-3 -->

    		<div class="col-sm-9">
                <div class="main-menu">
                	<!-- Static navbar -->
  					<div class="navbar navbar-default" role="navigation">
				        <div class="navbar-header">
				          	<button type="button" class="navbar-toggle" data-toggle="collapse" data-target=".navbar-collapse">
				            	<span class="sr-only">Toggle navigation</span>
				            	<span class="icon-bar"></span>
				            	<span class="icon-bar"></span>
				            	<span class="icon-bar"></span>
				          	</button>
				        </div>

				        <div class="navbar-collapse collapse">
          					<!-- Right nav -->		
											    	</div> <!-- /.end of collaspe navbar-collaspe -->
					</div>
                </div>
            </div> <!-- /.end of col-sm-9 -->
        </div>
    </div>
</section>


	<section class="page-header" style="background-image: url(  http://trials.hematology.tw/wp-content/themes/flatter/images/slider1.jpg  )">
	    <div class="container">
	        <div class="row">
	            <div class="col-sm-12">
	                <div class="block">
	                    <h1 class="page-title">NCKUH Hema Trials Dashboard</h1>
	                    <div class="underline"></div>
	                    	                </div>
	            </div>
	        </div>
	    </div>
	</section>

	<section class="inner-content">
    	<div class="container">
        	<div class="row">       		

				<div class="col-md-12 detail-content">
					
						
<article id="post-28" class="post-28 page type-page status-publish hentry">

    <div class="single-page">	
    
    	   

        <div class="content">
        	
<p class="has-medium-font-size"><strong>Leukemia 臨床試驗列表</strong></p>


<div class="wp2s2fg_fetcher_table_container "><table class="wp2s2fg_fetcher_table " style="border: none;"><thead class="wp2s2fg_fetcher_table_thead" style="border:none; : 1.3px solid #D1D1E4; "><tr class="wp2s2fg_fetcher_table_tr"><th class="wp2s2fg_fetcher_table_th " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1.3px solid #D1D1E4; text-align:#fff; background-color:#fff; ">試驗名稱</th><th class="wp2s2fg_fetcher_table_th " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1.3px solid #D1D1E4; text-align:#fff; background-color:#fff; ">診斷</th><th class="wp2s2fg_fetcher_table_th " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1.3px solid #D1D1E4; text-align:#fff; background-color:#fff; ">條件</th><th class="wp2s2fg_fetcher_table_th " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1.3px solid #D1D1E4; text-align:#fff; background-color:#fff; ">機轉</th><th class="wp2s2fg_fetcher_table_th " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1.3px solid #D1D1E4; text-align:#fff; background-color:#fff; ">年齡</th><th class="wp2s2fg_fetcher_table_th " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1.3px solid #D1D1E4; text-align:#fff; background-color:#fff; ">類型</th><th class="wp2s2fg_fetcher_table_th " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1.3px solid #D1D1E4; text-align:#fff; background-color:#fff; ">試驗組</th><th class="wp2s2fg_fetcher_table_th " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1.3px solid #D1D1E4; text-align:#fff; background-color:#fff; ">對照組</th><th class="wp2s2fg_fetcher_table_th " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1.3px solid #D1D1E4; text-align:#fff; background-color:#fff; ">預計收案</th><th class="wp2s2fg_fetcher_table_th " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1.3px solid #D1D1E4; text-align:#fff; background-color:#fff; ">已收案</th><th class="wp2s2fg_fetcher_table_th " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1.3px solid #D1D1E4; text-align:#fff; background-color:#fff; ">篩選失敗</th><th class="wp2s2fg_fetcher_table_th " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1.3px solid #D1D1E4; text-align:#fff; background-color:#fff; ">剩餘名額</th><th class="wp2s2fg_fetcher_table_th " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1.3px solid #D1D1E4; text-align:#fff; background-color:#fff; ">SN</th></thead></tr><tbody class="wp2s2fg_fetcher_table_tbody"><tr class="wp2s2fg_fetcher_table_tr"><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1.3px solid #D1D1E4; text-align:left; background-color:#fff; ">MK-1026-011</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1.3px solid #D1D1E4; text-align:left; background-color:#fff; ">CLL/SLL</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1.3px solid #D1D1E4; text-align:left; background-color:#fff; ">Untreated
</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1.3px solid #D1D1E4; text-align:left; background-color:#fff; ">BTK inhibitor</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1.3px solid #D1D1E4; text-align:left; background-color:#fff; ">≥20 years</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1.3px solid #D1D1E4; text-align:left; background-color:#fff; ">III</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1.3px solid #D1D1E4; text-align:left; background-color:#fff; ">Nemtabrutinib</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1.3px solid #D1D1E4; text-align:left; background-color:#fff; ">ibrutina/acalatinib</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1.3px solid #D1D1E4; text-align:left; background-color:#fff; ">7</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1.3px solid #D1D1E4; text-align:left; background-color:#fff; ">6</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1.3px solid #D1D1E4; text-align:left; background-color:#fff; ">1</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1.3px solid #D1D1E4; text-align:left; background-color:#fff; ">2</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1.3px solid #D1D1E4; text-align:left; background-color:#fff; ">李佳玲/4620</td></tr><tr class="wp2s2fg_fetcher_table_tr"><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1.3px solid #D1D1E4; text-align:left; background-color:#fff; ">BGB-16673-303</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1.3px solid #D1D1E4; text-align:left; background-color:#fff; ">CLL/SLL</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1.3px solid #D1D1E4; text-align:left; background-color:#fff; ">Relapsed/Refractory CLL/SLL 
(Exposed to Covalent BTK Inhibitors)</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1.3px solid #D1D1E4; text-align:left; background-color:#fff; ">BTK-targeting chimeric degradation activation compound (CDAC)</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1.3px solid #D1D1E4; text-align:left; background-color:#fff; ">≥18 years</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1.3px solid #D1D1E4; text-align:left; background-color:#fff; ">III</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1.3px solid #D1D1E4; text-align:left; background-color:#fff; ">Catadegbrutinib (BGB-16673)</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1.3px solid #D1D1E4; text-align:left; background-color:#fff; ">BR / 
high-dose methylprednisolone
+ rituximab (HDMP+R),</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1.3px solid #D1D1E4; text-align:left; background-color:#fff; ">4</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1.3px solid #D1D1E4; text-align:left; background-color:#fff; ">1</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1.3px solid #D1D1E4; text-align:left; background-color:#fff; ">0</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1.3px solid #D1D1E4; text-align:left; background-color:#fff; ">3</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1.3px solid #D1D1E4; text-align:left; background-color:#fff; ">李佳玲/4620</td></tr><tr class="wp2s2fg_fetcher_table_tr"><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1.3px solid #D1D1E4; text-align:left; background-color:#fff; ">20190360</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1.3px solid #D1D1E4; text-align:left; background-color:#fff; ">ALL</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1.3px solid #D1D1E4; text-align:left; background-color:#fff; ">untreated</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1.3px solid #D1D1E4; text-align:left; background-color:#fff; ">anti-CD19</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1.3px solid #D1D1E4; text-align:left; background-color:#fff; ">≥18 years</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1.3px solid #D1D1E4; text-align:left; background-color:#fff; ">III</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1.3px solid #D1D1E4; text-align:left; background-color:#fff; ">Blinatumomab</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1.3px solid #D1D1E4; text-align:left; background-color:#fff; ">GMALL
Hyper-CVAD</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1.3px solid #D1D1E4; text-align:left; background-color:#fff; ">4</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1.3px solid #D1D1E4; text-align:left; background-color:#fff; ">3</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1.3px solid #D1D1E4; text-align:left; background-color:#fff; ">0</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1.3px solid #D1D1E4; text-align:left; background-color:#fff; ">1</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1.3px solid #D1D1E4; text-align:left; background-color:#fff; ">李佳玲/4620</td></tr><tr class="wp2s2fg_fetcher_table_tr"><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1.3px solid #D1D1E4; text-align:left; background-color:#fff; ">D7405C00001</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1.3px solid #D1D1E4; text-align:left; background-color:#fff; ">CD19+ B-cell ALL (R/R)</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1.3px solid #D1D1E4; text-align:left; background-color:#fff; ">1.≥2 prior Tx
2. CD19(+)
3. PH(+)->至少兩線TKI failure or replase
4. PH(-)->至少兩線systemic therapy failure</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1.3px solid #D1D1E4; text-align:left; background-color:#fff; ">anti-CD19/CD3</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1.3px solid #D1D1E4; text-align:left; background-color:#fff; ">1. ≥12 years
2. CD19+</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1.3px solid #D1D1E4; text-align:left; background-color:#fff; ">I/ II</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1.3px solid #D1D1E4; text-align:left; background-color:#fff; ">AZD0486</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1.3px solid #D1D1E4; text-align:left; background-color:#fff; "></td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1.3px solid #D1D1E4; text-align:left; background-color:#fff; ">3</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1.3px solid #D1D1E4; text-align:left; background-color:#fff; ">0</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1.3px solid #D1D1E4; text-align:left; background-color:#fff; ">0</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1.3px solid #D1D1E4; text-align:left; background-color:#fff; ">0</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1.3px solid #D1D1E4; text-align:left; background-color:#fff; ">吳軒綾/3998</td></tr><tr class="wp2s2fg_fetcher_table_tr"><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1.3px solid #D1D1E4; text-align:left; background-color:#fff; ">DSP-5336-101</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1.3px solid #D1D1E4; text-align:left; background-color:#fff; ">Phase I: AML(R/R), ALL(R/R)
Phase II: MLLr/ NPM1m AML</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1.3px solid #D1D1E4; text-align:left; background-color:#fff; ">4 cycle HMA/ LDAC or 2 cycle combination therapy failure for refractory group</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1.3px solid #D1D1E4; text-align:left; background-color:#fff; ">Menin inhibitor</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1.3px solid #D1D1E4; text-align:left; background-color:#fff; ">≥18 years</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1.3px solid #D1D1E4; text-align:left; background-color:#fff; ">I/ II</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1.3px solid #D1D1E4; text-align:left; background-color:#fff; ">DSP-5336</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1.3px solid #D1D1E4; text-align:left; background-color:#fff; "></td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1.3px solid #D1D1E4; text-align:left; background-color:#fff; ">3</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1.3px solid #D1D1E4; text-align:left; background-color:#fff; ">0</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1.3px solid #D1D1E4; text-align:left; background-color:#fff; ">0</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1.3px solid #D1D1E4; text-align:left; background-color:#fff; ">0</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1.3px solid #D1D1E4; text-align:left; background-color:#fff; ">鄭采涵/3974</td></tr><tr class="wp2s2fg_fetcher_table_tr"><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1.3px solid #D1D1E4; text-align:left; background-color:#fff; ">75276617ALE1001</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1.3px solid #D1D1E4; text-align:left; background-color:#fff; ">KMT2A-r/ NPM1m AML</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1.3px solid #D1D1E4; text-align:left; background-color:#fff; ">Cohort A1: KMT2A-r AML
Cohort A2: NPM1m AML</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1.3px solid #D1D1E4; text-align:left; background-color:#fff; ">Menin-KMT2A (MLL1) inhibitor</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1.3px solid #D1D1E4; text-align:left; background-color:#fff; "> ≥18 years</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1.3px solid #D1D1E4; text-align:left; background-color:#fff; ">II</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1.3px solid #D1D1E4; text-align:left; background-color:#fff; ">Bleximenib</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1.3px solid #D1D1E4; text-align:left; background-color:#fff; "></td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1.3px solid #D1D1E4; text-align:left; background-color:#fff; ">2</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1.3px solid #D1D1E4; text-align:left; background-color:#fff; "></td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1.3px solid #D1D1E4; text-align:left; background-color:#fff; ">2</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1.3px solid #D1D1E4; text-align:left; background-color:#fff; "></td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1.3px solid #D1D1E4; text-align:left; background-color:#fff; ">李佳玲/4620</td></tr><tr class="wp2s2fg_fetcher_table_tr"><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1.3px solid #D1D1E4; text-align:left; background-color:#fff; ">AC220-168</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1.3px solid #D1D1E4; text-align:left; background-color:#fff; ">AML</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1.3px solid #D1D1E4; text-align:left; background-color:#fff; ">Untreated &#038; FLT3-ITD(-)</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1.3px solid #D1D1E4; text-align:left; background-color:#fff; ">class III receptor tyrosine kinases</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1.3px solid #D1D1E4; text-align:left; background-color:#fff; "> ≥18 years</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1.3px solid #D1D1E4; text-align:left; background-color:#fff; ">III</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1.3px solid #D1D1E4; text-align:left; background-color:#fff; ">Quizartinib/ Placebo</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1.3px solid #D1D1E4; text-align:left; background-color:#fff; "></td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1.3px solid #D1D1E4; text-align:left; background-color:#fff; ">4</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1.3px solid #D1D1E4; text-align:left; background-color:#fff; ">1</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1.3px solid #D1D1E4; text-align:left; background-color:#fff; ">3</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1.3px solid #D1D1E4; text-align:left; background-color:#fff; "></td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1.3px solid #D1D1E4; text-align:left; background-color:#fff; ">李佳玲/4620</td></tr><tr class="wp2s2fg_fetcher_table_tr"><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1.3px solid #D1D1E4; text-align:left; background-color:#fff; ">KER-050-D301</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1.3px solid #D1D1E4; text-align:left; background-color:#fff; ">MDS</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1.3px solid #D1D1E4; text-align:left; background-color:#fff; ">very low-, low-, intermediate risk MDS</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1.3px solid #D1D1E4; text-align:left; background-color:#fff; ">tgf-β ligand</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1.3px solid #D1D1E4; text-align:left; background-color:#fff; ">≥18 years</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1.3px solid #D1D1E4; text-align:left; background-color:#fff; ">III</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1.3px solid #D1D1E4; text-align:left; background-color:#fff; ">Elritercept/ placebo</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1.3px solid #D1D1E4; text-align:left; background-color:#fff; "></td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1.3px solid #D1D1E4; text-align:left; background-color:#fff; "></td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1.3px solid #D1D1E4; text-align:left; background-color:#fff; "></td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1.3px solid #D1D1E4; text-align:left; background-color:#fff; "></td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1.3px solid #D1D1E4; text-align:left; background-color:#fff; "></td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1.3px solid #D1D1E4; text-align:left; background-color:#fff; ">李佳玲/4620</td></tbody></tr><tfoot class="wp2s2fg_fetcher_table_tfoot"><tr class="wp2s2fg_fetcher_table_tr"><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1.3px solid #D1D1E4; text-align:left; background-color:#fff; ">ZE46-0134-0002-US</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1.3px solid #D1D1E4; text-align:left; background-color:#fff; ">AML (R/R)</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1.3px solid #D1D1E4; text-align:left; background-color:#fff; ">Group 1: FLT3 ITD/TDK mutation
Group 2: Spliceosome Mutation (SF3B1, SRSF2, U2AF1, ZRSR2)</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1.3px solid #D1D1E4; text-align:left; background-color:#fff; ">FLT3 inhibitors</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1.3px solid #D1D1E4; text-align:left; background-color:#fff; ">≥18 years</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1.3px solid #D1D1E4; text-align:left; background-color:#fff; ">I</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1.3px solid #D1D1E4; text-align:left; background-color:#fff; ">ZE46-0134</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1.3px solid #D1D1E4; text-align:left; background-color:#fff; "></td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1.3px solid #D1D1E4; text-align:left; background-color:#fff; "></td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1.3px solid #D1D1E4; text-align:left; background-color:#fff; "></td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1.3px solid #D1D1E4; text-align:left; background-color:#fff; "></td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1.3px solid #D1D1E4; text-align:left; background-color:#fff; "></td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1.3px solid #D1D1E4; text-align:left; background-color:#fff; ">李佳玲/4620</td></tfoot></tr></table></div>


<p></p>



<p class="has-medium-font-size"><strong>Lymphoma 臨床試驗列表</strong></p>


<div class="wp2s2fg_fetcher_table_container "><table class="wp2s2fg_fetcher_table " style="border: none;"><thead class="wp2s2fg_fetcher_table_thead" style="border:none; : 0.1rem solid #ccc; "><tr class="wp2s2fg_fetcher_table_tr"><th class="wp2s2fg_fetcher_table_th " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border-bottom: 0.1rem solid #ccc; text-align:#fff; background-color:#fff; ">試驗名稱</th><th class="wp2s2fg_fetcher_table_th " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border-bottom: 0.1rem solid #ccc; text-align:#fff; background-color:#fff; ">診斷</th><th class="wp2s2fg_fetcher_table_th " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border-bottom: 0.1rem solid #ccc; text-align:#fff; background-color:#fff; ">條件</th><th class="wp2s2fg_fetcher_table_th " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border-bottom: 0.1rem solid #ccc; text-align:#fff; background-color:#fff; ">機轉</th><th class="wp2s2fg_fetcher_table_th " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border-bottom: 0.1rem solid #ccc; text-align:#fff; background-color:#fff; ">類型</th><th class="wp2s2fg_fetcher_table_th " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border-bottom: 0.1rem solid #ccc; text-align:#fff; background-color:#fff; ">試驗組</th><th class="wp2s2fg_fetcher_table_th " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border-bottom: 0.1rem solid #ccc; text-align:#fff; background-color:#fff; ">對照組</th><th class="wp2s2fg_fetcher_table_th " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border-bottom: 0.1rem solid #ccc; text-align:#fff; background-color:#fff; ">預計收案</th><th class="wp2s2fg_fetcher_table_th " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border-bottom: 0.1rem solid #ccc; text-align:#fff; background-color:#fff; ">已收案</th><th class="wp2s2fg_fetcher_table_th " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border-bottom: 0.1rem solid #ccc; text-align:#fff; background-color:#fff; ">篩選失敗</th><th class="wp2s2fg_fetcher_table_th " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border-bottom: 0.1rem solid #ccc; text-align:#fff; background-color:#fff; ">剩餘</th><th class="wp2s2fg_fetcher_table_th " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border-bottom: 0.1rem solid #ccc; text-align:#fff; background-color:#fff; ">SN</th></thead></tr><tbody class="wp2s2fg_fetcher_table_tbody"><tr class="wp2s2fg_fetcher_table_tr"><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border-bottom: 0.1rem solid #ccc; text-align:left; background-color:#fff; ">R1979-ONC-2210
(Olympia-5)</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border-bottom: 0.1rem solid #ccc; text-align:left; background-color:#fff; ">1. FL G1-3a
2. MZL
</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border-bottom: 0.1rem solid #ccc; text-align:left; background-color:#fff; ">1.R/R
2.≥1 prior Tx</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border-bottom: 0.1rem solid #ccc; text-align:left; background-color:#fff; ">CD20+CD3 bispecific Ab</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border-bottom: 0.1rem solid #ccc; text-align:left; background-color:#fff; ">III</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border-bottom: 0.1rem solid #ccc; text-align:left; background-color:#fff; ">Odronextamab+ Lenalidomide</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border-bottom: 0.1rem solid #ccc; text-align:left; background-color:#fff; ">R2</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border-bottom: 0.1rem solid #ccc; text-align:left; background-color:#fff; ">3</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border-bottom: 0.1rem solid #ccc; text-align:left; background-color:#fff; ">0</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border-bottom: 0.1rem solid #ccc; text-align:left; background-color:#fff; ">0</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border-bottom: 0.1rem solid #ccc; text-align:left; background-color:#fff; ">3</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border-bottom: 0.1rem solid #ccc; text-align:left; background-color:#fff; ">溫上容/3998</td></tr><tr class="wp2s2fg_fetcher_table_tr"><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border-bottom: 0.1rem solid #ccc; text-align:left; background-color:#fff; ">R1979-HM-2299
(Olympia-4)</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border-bottom: 0.1rem solid #ccc; text-align:left; background-color:#fff; ">r/r aggressive B-cell lymphoma</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border-bottom: 0.1rem solid #ccc; text-align:left; background-color:#fff; ">1. DLBCL(de novo or transformed indolent NHL, high-grade B with MYC+BCL2 ± BCL6
2. r/r within 12m from 1st treatment </td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border-bottom: 0.1rem solid #ccc; text-align:left; background-color:#fff; ">CD20+CD3 bispecific Ab</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border-bottom: 0.1rem solid #ccc; text-align:left; background-color:#fff; ">III</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border-bottom: 0.1rem solid #ccc; text-align:left; background-color:#fff; ">Odronextamab</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border-bottom: 0.1rem solid #ccc; text-align:left; background-color:#fff; ">R-ICE
R-DHAP
R-GDP</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border-bottom: 0.1rem solid #ccc; text-align:left; background-color:#fff; ">3</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border-bottom: 0.1rem solid #ccc; text-align:left; background-color:#fff; ">1</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border-bottom: 0.1rem solid #ccc; text-align:left; background-color:#fff; ">0</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border-bottom: 0.1rem solid #ccc; text-align:left; background-color:#fff; ">2</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border-bottom: 0.1rem solid #ccc; text-align:left; background-color:#fff; ">劉璟穎/6452</td></tr><tr class="wp2s2fg_fetcher_table_tr"><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border-bottom: 0.1rem solid #ccc; text-align:left; background-color:#fff; ">ACE1831-001
</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border-bottom: 0.1rem solid #ccc; text-align:left; background-color:#fff; ">NHL 
</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border-bottom: 0.1rem solid #ccc; text-align:left; background-color:#fff; ">R/R
</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border-bottom: 0.1rem solid #ccc; text-align:left; background-color:#fff; ">ACC(CAR-T)</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border-bottom: 0.1rem solid #ccc; text-align:left; background-color:#fff; ">I b/ II</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border-bottom: 0.1rem solid #ccc; text-align:left; background-color:#fff; ">ACE1831</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border-bottom: 0.1rem solid #ccc; text-align:left; background-color:#fff; "></td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border-bottom: 0.1rem solid #ccc; text-align:left; background-color:#fff; ">4</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border-bottom: 0.1rem solid #ccc; text-align:left; background-color:#fff; ">2</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border-bottom: 0.1rem solid #ccc; text-align:left; background-color:#fff; ">1</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border-bottom: 0.1rem solid #ccc; text-align:left; background-color:#fff; ">3</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border-bottom: 0.1rem solid #ccc; text-align:left; background-color:#fff; ">鄭采涵/3974</td></tr><tr class="wp2s2fg_fetcher_table_tr"><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border-bottom: 0.1rem solid #ccc; text-align:left; background-color:#fff; ">M22-003</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border-bottom: 0.1rem solid #ccc; text-align:left; background-color:#fff; ">FL Gr 1, Gr 2, or Gr 3a(CD20+)</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border-bottom: 0.1rem solid #ccc; text-align:left; background-color:#fff; ">newly diagnosed + stage, III or IV disease, or stage II with bulky disease</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border-bottom: 0.1rem solid #ccc; text-align:left; background-color:#fff; ">CD20+CD3 bispecific Ab</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border-bottom: 0.1rem solid #ccc; text-align:left; background-color:#fff; ">III</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border-bottom: 0.1rem solid #ccc; text-align:left; background-color:#fff; ">Epcoritamab+ R2</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border-bottom: 0.1rem solid #ccc; text-align:left; background-color:#fff; ">Arm B: G-CHOP/ R-CHOP/ BR
Arm C: R2</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border-bottom: 0.1rem solid #ccc; text-align:left; background-color:#fff; ">5</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border-bottom: 0.1rem solid #ccc; text-align:left; background-color:#fff; ">4</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border-bottom: 0.1rem solid #ccc; text-align:left; background-color:#fff; ">0</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border-bottom: 0.1rem solid #ccc; text-align:left; background-color:#fff; ">1</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border-bottom: 0.1rem solid #ccc; text-align:left; background-color:#fff; ">鄭采涵/3974</td></tr><tr class="wp2s2fg_fetcher_table_tr"><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border-bottom: 0.1rem solid #ccc; text-align:left; background-color:#fff; ">EZH-302</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border-bottom: 0.1rem solid #ccc; text-align:left; background-color:#fff; ">FL Gr 1, Gr 2, or Gr 3a</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border-bottom: 0.1rem solid #ccc; text-align:left; background-color:#fff; ">≥1 prior Tx</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border-bottom: 0.1rem solid #ccc; text-align:left; background-color:#fff; ">EZH 2 innibitor</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border-bottom: 0.1rem solid #ccc; text-align:left; background-color:#fff; ">III</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border-bottom: 0.1rem solid #ccc; text-align:left; background-color:#fff; ">Tazemetostat+ R2</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border-bottom: 0.1rem solid #ccc; text-align:left; background-color:#fff; ">placebo +R2</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border-bottom: 0.1rem solid #ccc; text-align:left; background-color:#fff; ">6</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border-bottom: 0.1rem solid #ccc; text-align:left; background-color:#fff; ">6</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border-bottom: 0.1rem solid #ccc; text-align:left; background-color:#fff; ">2</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border-bottom: 0.1rem solid #ccc; text-align:left; background-color:#fff; ">2</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border-bottom: 0.1rem solid #ccc; text-align:left; background-color:#fff; ">鄭采涵/3974</td></tr><tr class="wp2s2fg_fetcher_table_tr"><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border-bottom: 0.1rem solid #ccc; text-align:left; background-color:#fff; ">D7400C00006</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border-bottom: 0.1rem solid #ccc; text-align:left; background-color:#fff; ">1. DLBCL
2. High-grad B cell (MYC+BCL2/BCL6)</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border-bottom: 0.1rem solid #ccc; text-align:left; background-color:#fff; ">1. R/R 
2. ≥2 prior Tx</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border-bottom: 0.1rem solid #ccc; text-align:left; background-color:#fff; ">CD19+CD3 bispecific Ab</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border-bottom: 0.1rem solid #ccc; text-align:left; background-color:#fff; ">I</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border-bottom: 0.1rem solid #ccc; text-align:left; background-color:#fff; ">AZD0486(TNB-486)</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border-bottom: 0.1rem solid #ccc; text-align:left; background-color:#fff; "></td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border-bottom: 0.1rem solid #ccc; text-align:left; background-color:#fff; ">5</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border-bottom: 0.1rem solid #ccc; text-align:left; background-color:#fff; ">3</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border-bottom: 0.1rem solid #ccc; text-align:left; background-color:#fff; ">1</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border-bottom: 0.1rem solid #ccc; text-align:left; background-color:#fff; ">3</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border-bottom: 0.1rem solid #ccc; text-align:left; background-color:#fff; ">鄭采涵/3974</td></tr><tr class="wp2s2fg_fetcher_table_tr"><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border-bottom: 0.1rem solid #ccc; text-align:left; background-color:#fff; ">DR-01-ONC-001</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border-bottom: 0.1rem solid #ccc; text-align:left; background-color:#fff; ">1. Cytotoxic T cell Lymphomas
2. LGL</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border-bottom: 0.1rem solid #ccc; text-align:left; background-color:#fff; ">≥1 prior Tx</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border-bottom: 0.1rem solid #ccc; text-align:left; background-color:#fff; ">human IgG1 antibody against CD94,</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border-bottom: 0.1rem solid #ccc; text-align:left; background-color:#fff; ">I/II</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border-bottom: 0.1rem solid #ccc; text-align:left; background-color:#fff; ">DR-01</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border-bottom: 0.1rem solid #ccc; text-align:left; background-color:#fff; "></td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border-bottom: 0.1rem solid #ccc; text-align:left; background-color:#fff; ">2</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border-bottom: 0.1rem solid #ccc; text-align:left; background-color:#fff; ">2</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border-bottom: 0.1rem solid #ccc; text-align:left; background-color:#fff; ">2</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border-bottom: 0.1rem solid #ccc; text-align:left; background-color:#fff; ">2</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border-bottom: 0.1rem solid #ccc; text-align:left; background-color:#fff; ">李佳玲/4620</td></tr><tr class="wp2s2fg_fetcher_table_tr"><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border-bottom: 0.1rem solid #ccc; text-align:left; background-color:#fff; ">DZ2022J0004</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border-bottom: 0.1rem solid #ccc; text-align:left; background-color:#fff; ">PTCL
AITL</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border-bottom: 0.1rem solid #ccc; text-align:left; background-color:#fff; ">≥1 prior Tx</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border-bottom: 0.1rem solid #ccc; text-align:left; background-color:#fff; ">JAK 1</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border-bottom: 0.1rem solid #ccc; text-align:left; background-color:#fff; ">III</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border-bottom: 0.1rem solid #ccc; text-align:left; background-color:#fff; ">Golidicitinib</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border-bottom: 0.1rem solid #ccc; text-align:left; background-color:#fff; ">Pralatrexate(缺藥)
Belinostat
Gemcitabine
Chidamide</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border-bottom: 0.1rem solid #ccc; text-align:left; background-color:#fff; ">4</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border-bottom: 0.1rem solid #ccc; text-align:left; background-color:#fff; ">3</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border-bottom: 0.1rem solid #ccc; text-align:left; background-color:#fff; "></td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border-bottom: 0.1rem solid #ccc; text-align:left; background-color:#fff; ">1</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border-bottom: 0.1rem solid #ccc; text-align:left; background-color:#fff; ">李佳玲/4620</td></tr><tr class="wp2s2fg_fetcher_table_tr"><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border-bottom: 0.1rem solid #ccc; text-align:left; background-color:#fff; ">D7404C00001
(SOUNDTRACK-B)</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border-bottom: 0.1rem solid #ccc; text-align:left; background-color:#fff; ">module 1: FL (will be recruiting)
module 2: DLBCL </td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border-bottom: 0.1rem solid #ccc; text-align:left; background-color:#fff; ">1. R/R 
2. ≥2 prior Tx</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border-bottom: 0.1rem solid #ccc; text-align:left; background-color:#fff; ">CD19+CD3 bispecific Ab</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border-bottom: 0.1rem solid #ccc; text-align:left; background-color:#fff; ">II</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border-bottom: 0.1rem solid #ccc; text-align:left; background-color:#fff; ">AZD0486</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border-bottom: 0.1rem solid #ccc; text-align:left; background-color:#fff; ">Single-Arm (-)</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border-bottom: 0.1rem solid #ccc; text-align:left; background-color:#fff; "></td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border-bottom: 0.1rem solid #ccc; text-align:left; background-color:#fff; ">2</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border-bottom: 0.1rem solid #ccc; text-align:left; background-color:#fff; "></td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border-bottom: 0.1rem solid #ccc; text-align:left; background-color:#fff; "></td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border-bottom: 0.1rem solid #ccc; text-align:left; background-color:#fff; ">李佳玲/4620</td></tr><tr class="wp2s2fg_fetcher_table_tr"><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border-bottom: 0.1rem solid #ccc; text-align:left; background-color:#fff; ">D7401C00001</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border-bottom: 0.1rem solid #ccc; text-align:left; background-color:#fff; ">FL Gr 1, Gr 2, or Gr 3a</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border-bottom: 0.1rem solid #ccc; text-align:left; background-color:#fff; ">newly diagnosed + stage, III or IV disease, or stage II with bulky disease</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border-bottom: 0.1rem solid #ccc; text-align:left; background-color:#fff; ">CD19+CD3 bispecific Ab</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border-bottom: 0.1rem solid #ccc; text-align:left; background-color:#fff; ">III</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border-bottom: 0.1rem solid #ccc; text-align:left; background-color:#fff; ">AZD0486</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border-bottom: 0.1rem solid #ccc; text-align:left; background-color:#fff; ">AZD0486+Rituximab</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border-bottom: 0.1rem solid #ccc; text-align:left; background-color:#fff; ">10</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border-bottom: 0.1rem solid #ccc; text-align:left; background-color:#fff; ">1</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border-bottom: 0.1rem solid #ccc; text-align:left; background-color:#fff; ">1</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border-bottom: 0.1rem solid #ccc; text-align:left; background-color:#fff; ">10</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border-bottom: 0.1rem solid #ccc; text-align:left; background-color:#fff; ">吳宜真/3974</td></tbody></tr><tfoot class="wp2s2fg_fetcher_table_tfoot"><tr class="wp2s2fg_fetcher_table_tr"><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border-bottom: 0.1rem solid #ccc; text-align:left; background-color:#fff; ">M22-132
(名額需問slot)
</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border-bottom: 0.1rem solid #ccc; text-align:left; background-color:#fff; ">
DLBLC 
</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border-bottom: 0.1rem solid #ccc; text-align:left; background-color:#fff; ">Newly diagnosed 
</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border-bottom: 0.1rem solid #ccc; text-align:left; background-color:#fff; ">CD20+CD3 bispecific Ab</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border-bottom: 0.1rem solid #ccc; text-align:left; background-color:#fff; ">I b/ II</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border-bottom: 0.1rem solid #ccc; text-align:left; background-color:#fff; ">Epcoritamab + Polatuzumab +RCHP
   </td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border-bottom: 0.1rem solid #ccc; text-align:left; background-color:#fff; "></td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border-bottom: 0.1rem solid #ccc; text-align:left; background-color:#fff; "></td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border-bottom: 0.1rem solid #ccc; text-align:left; background-color:#fff; ">2</td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border-bottom: 0.1rem solid #ccc; text-align:left; background-color:#fff; "></td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border-bottom: 0.1rem solid #ccc; text-align:left; background-color:#fff; "></td><td class="wp2s2fg_fetcher_table_td " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border-bottom: 0.1rem solid #ccc; text-align:left; background-color:#fff; ">李佳玲/4620</td></tfoot></tr></table></div>


<p></p>



<p>Others臨床試驗列表</p>


<div class="wp2s2fg_fetcher_table_container "><table class="wp2s2fg_fetcher_table " style="border: none;"><thead class="wp2s2fg_fetcher_table_thead" style="border:none; : 1px solid #ccc; "><tr class="wp2s2fg_fetcher_table_tr"><th class="wp2s2fg_fetcher_table_th " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1px solid #ccc; text-align:#fff; background-color:#fff; ">試驗名稱</th><th class="wp2s2fg_fetcher_table_th " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1px solid #ccc; text-align:#fff; background-color:#fff; ">診斷</th><th class="wp2s2fg_fetcher_table_th " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1px solid #ccc; text-align:#fff; background-color:#fff; ">條件</th><th class="wp2s2fg_fetcher_table_th " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1px solid #ccc; text-align:#fff; background-color:#fff; ">機轉</th><th class="wp2s2fg_fetcher_table_th " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1px solid #ccc; text-align:#fff; background-color:#fff; ">類型</th><th class="wp2s2fg_fetcher_table_th " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1px solid #ccc; text-align:#fff; background-color:#fff; ">試驗組</th><th class="wp2s2fg_fetcher_table_th " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1px solid #ccc; text-align:#fff; background-color:#fff; ">對照組</th><th class="wp2s2fg_fetcher_table_th " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1px solid #ccc; text-align:#fff; background-color:#fff; ">預計收案</th><th class="wp2s2fg_fetcher_table_th " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1px solid #ccc; text-align:#fff; background-color:#fff; ">已收案</th><th class="wp2s2fg_fetcher_table_th " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1px solid #ccc; text-align:#fff; background-color:#fff; ">篩選失敗</th><th class="wp2s2fg_fetcher_table_th " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1px solid #ccc; text-align:#fff; background-color:#fff; ">剩餘</th><th class="wp2s2fg_fetcher_table_th " style="font-size:14px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1px solid #ccc; text-align:#fff; background-color:#fff; ">SN</th></thead></tr><tbody class="wp2s2fg_fetcher_table_tbody"><tr class="wp2s2fg_fetcher_table_tr"><td class="wp2s2fg_fetcher_table_td " style="font-size:12px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1px solid #ccc; text-align:left; background-color:#fff; ">R3918-PNH-2021</td><td class="wp2s2fg_fetcher_table_td " style="font-size:12px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1px solid #ccc; text-align:left; background-color:#fff; ">PNH</td><td class="wp2s2fg_fetcher_table_td " style="font-size:12px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1px solid #ccc; text-align:left; background-color:#fff; ">Untreat or 
Eculizumab stop over 3 m or
Ravulizumab stop over 6 m</td><td class="wp2s2fg_fetcher_table_td " style="font-size:12px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1px solid #ccc; text-align:left; background-color:#fff; ">C5 inhibitor</td><td class="wp2s2fg_fetcher_table_td " style="font-size:12px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1px solid #ccc; text-align:left; background-color:#fff; ">III</td><td class="wp2s2fg_fetcher_table_td " style="font-size:12px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1px solid #ccc; text-align:left; background-color:#fff; ">C5 inhibitor</td><td class="wp2s2fg_fetcher_table_td " style="font-size:12px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1px solid #ccc; text-align:left; background-color:#fff; ">Eculizumab</td><td class="wp2s2fg_fetcher_table_td " style="font-size:12px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1px solid #ccc; text-align:left; background-color:#fff; "></td><td class="wp2s2fg_fetcher_table_td " style="font-size:12px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1px solid #ccc; text-align:left; background-color:#fff; "></td><td class="wp2s2fg_fetcher_table_td " style="font-size:12px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1px solid #ccc; text-align:left; background-color:#fff; "></td><td class="wp2s2fg_fetcher_table_td " style="font-size:12px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1px solid #ccc; text-align:left; background-color:#fff; "></td><td class="wp2s2fg_fetcher_table_td " style="font-size:12px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1px solid #ccc; text-align:left; background-color:#fff; ">李佳玲/4620</td></tr><tr class="wp2s2fg_fetcher_table_tr"><td class="wp2s2fg_fetcher_table_td " style="font-size:12px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1px solid #ccc; text-align:left; background-color:#fff; ">MK3543-007</td><td class="wp2s2fg_fetcher_table_td " style="font-size:12px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1px solid #ccc; text-align:left; background-color:#fff; ">ET</td><td class="wp2s2fg_fetcher_table_td " style="font-size:12px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1px solid #ccc; text-align:left; background-color:#fff; ">untreat </td><td class="wp2s2fg_fetcher_table_td " style="font-size:12px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1px solid #ccc; text-align:left; background-color:#fff; ">LSD1</td><td class="wp2s2fg_fetcher_table_td " style="font-size:12px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1px solid #ccc; text-align:left; background-color:#fff; ">III</td><td class="wp2s2fg_fetcher_table_td " style="font-size:12px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1px solid #ccc; text-align:left; background-color:#fff; ">MK3543/Hydroxyurea(placebo)</td><td class="wp2s2fg_fetcher_table_td " style="font-size:12px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1px solid #ccc; text-align:left; background-color:#fff; ">Hydroxyurea(placebo)/MK3543</td><td class="wp2s2fg_fetcher_table_td " style="font-size:12px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1px solid #ccc; text-align:left; background-color:#fff; "></td><td class="wp2s2fg_fetcher_table_td " style="font-size:12px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1px solid #ccc; text-align:left; background-color:#fff; "></td><td class="wp2s2fg_fetcher_table_td " style="font-size:12px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1px solid #ccc; text-align:left; background-color:#fff; "></td><td class="wp2s2fg_fetcher_table_td " style="font-size:12px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1px solid #ccc; text-align:left; background-color:#fff; "></td><td class="wp2s2fg_fetcher_table_td " style="font-size:12px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1px solid #ccc; text-align:left; background-color:#fff; ">李佳玲/4620</td></tbody></tr><tfoot class="wp2s2fg_fetcher_table_tfoot"><tr class="wp2s2fg_fetcher_table_tr"><td class="wp2s2fg_fetcher_table_td " style="font-size:12px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1px solid #ccc; text-align:left; background-color:#fff; ">KRT-232-115</td><td class="wp2s2fg_fetcher_table_td " style="font-size:12px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1px solid #ccc; text-align:left; background-color:#fff; ">MF5</td><td class="wp2s2fg_fetcher_table_td " style="font-size:12px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1px solid #ccc; text-align:left; background-color:#fff; ">JAK inhibitor naive</td><td class="wp2s2fg_fetcher_table_td " style="font-size:12px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1px solid #ccc; text-align:left; background-color:#fff; ">MDM2</td><td class="wp2s2fg_fetcher_table_td " style="font-size:12px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1px solid #ccc; text-align:left; background-color:#fff; ">III</td><td class="wp2s2fg_fetcher_table_td " style="font-size:12px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1px solid #ccc; text-align:left; background-color:#fff; ">Navtemadlin + Ruxolitinib</td><td class="wp2s2fg_fetcher_table_td " style="font-size:12px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1px solid #ccc; text-align:left; background-color:#fff; ">Navtemadlin(placebo) + Ruxolitinib</td><td class="wp2s2fg_fetcher_table_td " style="font-size:12px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1px solid #ccc; text-align:left; background-color:#fff; "></td><td class="wp2s2fg_fetcher_table_td " style="font-size:12px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1px solid #ccc; text-align:left; background-color:#fff; "></td><td class="wp2s2fg_fetcher_table_td " style="font-size:12px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1px solid #ccc; text-align:left; background-color:#fff; "></td><td class="wp2s2fg_fetcher_table_td " style="font-size:12px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1px solid #ccc; text-align:left; background-color:#fff; "></td><td class="wp2s2fg_fetcher_table_td " style="font-size:12px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1px solid #ccc; text-align:left; background-color:#fff; ">李佳玲/4620</td></tfoot></tr></table></div>


<p></p>



<p>Multiple Myeloma臨床試驗案</p>


<div class="wp2s2fg_fetcher_table_container "><table class="wp2s2fg_fetcher_table " style="border: none;"><thead class="wp2s2fg_fetcher_table_thead" style="border:none; : 1px solid #ccc; "><tr class="wp2s2fg_fetcher_table_tr"><th class="wp2s2fg_fetcher_table_th " style="font-size:16px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1px solid #ccc; text-align:#fff; background-color:#fff; ">試驗名稱</th><th class="wp2s2fg_fetcher_table_th " style="font-size:16px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1px solid #ccc; text-align:#fff; background-color:#fff; ">診斷</th><th class="wp2s2fg_fetcher_table_th " style="font-size:16px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1px solid #ccc; text-align:#fff; background-color:#fff; ">條件</th><th class="wp2s2fg_fetcher_table_th " style="font-size:16px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1px solid #ccc; text-align:#fff; background-color:#fff; ">機轉</th><th class="wp2s2fg_fetcher_table_th " style="font-size:16px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1px solid #ccc; text-align:#fff; background-color:#fff; ">類型</th><th class="wp2s2fg_fetcher_table_th " style="font-size:16px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1px solid #ccc; text-align:#fff; background-color:#fff; ">試驗組</th><th class="wp2s2fg_fetcher_table_th " style="font-size:16px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1px solid #ccc; text-align:#fff; background-color:#fff; ">對照組</th><th class="wp2s2fg_fetcher_table_th " style="font-size:16px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1px solid #ccc; text-align:#fff; background-color:#fff; ">預計收案</th><th class="wp2s2fg_fetcher_table_th " style="font-size:16px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1px solid #ccc; text-align:#fff; background-color:#fff; ">已收案</th><th class="wp2s2fg_fetcher_table_th " style="font-size:16px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1px solid #ccc; text-align:#fff; background-color:#fff; ">篩選失敗</th><th class="wp2s2fg_fetcher_table_th " style="font-size:16px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1px solid #ccc; text-align:#fff; background-color:#fff; ">剩餘</th><th class="wp2s2fg_fetcher_table_th " style="font-size:16px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1px solid #ccc; text-align:#fff; background-color:#fff; ">SN</th></thead></tr><tbody class="wp2s2fg_fetcher_table_tbody"><tr class="wp2s2fg_fetcher_table_tr"><td class="wp2s2fg_fetcher_table_td " style="font-size:16px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1px solid #ccc; text-align:left; background-color:#fff; ">CT-P44 3.1</td><td class="wp2s2fg_fetcher_table_td " style="font-size:16px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1px solid #ccc; text-align:left; background-color:#fff; ">MM</td><td class="wp2s2fg_fetcher_table_td " style="font-size:16px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1px solid #ccc; text-align:left; background-color:#fff; ">≥1 prior Tx(Including Lenalidomide )</td><td class="wp2s2fg_fetcher_table_td " style="font-size:16px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1px solid #ccc; text-align:left; background-color:#fff; ">CD38+</td><td class="wp2s2fg_fetcher_table_td " style="font-size:16px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1px solid #ccc; text-align:left; background-color:#fff; ">III</td><td class="wp2s2fg_fetcher_table_td " style="font-size:16px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1px solid #ccc; text-align:left; background-color:#fff; ">CT-P44+Lena+Dexa</td><td class="wp2s2fg_fetcher_table_td " style="font-size:16px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1px solid #ccc; text-align:left; background-color:#fff; ">DRd</td><td class="wp2s2fg_fetcher_table_td " style="font-size:16px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1px solid #ccc; text-align:left; background-color:#fff; ">10</td><td class="wp2s2fg_fetcher_table_td " style="font-size:16px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1px solid #ccc; text-align:left; background-color:#fff; ">0</td><td class="wp2s2fg_fetcher_table_td " style="font-size:16px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1px solid #ccc; text-align:left; background-color:#fff; ">0</td><td class="wp2s2fg_fetcher_table_td " style="font-size:16px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1px solid #ccc; text-align:left; background-color:#fff; ">10</td><td class="wp2s2fg_fetcher_table_td " style="font-size:16px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1px solid #ccc; text-align:left; background-color:#fff; ">溫上容/3998</td></tr><tr class="wp2s2fg_fetcher_table_tr"><td class="wp2s2fg_fetcher_table_td " style="font-size:16px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1px solid #ccc; text-align:left; background-color:#fff; ">IM048-022
(EXCALIBER-Maint))</td><td class="wp2s2fg_fetcher_table_td " style="font-size:16px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1px solid #ccc; text-align:left; background-color:#fff; ">MM</td><td class="wp2s2fg_fetcher_table_td " style="font-size:16px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1px solid #ccc; text-align:left; background-color:#fff; ">after ASCT with NDMM</td><td class="wp2s2fg_fetcher_table_td " style="font-size:16px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1px solid #ccc; text-align:left; background-color:#fff; ">CUL4-CRBN E3-Bite</td><td class="wp2s2fg_fetcher_table_td " style="font-size:16px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1px solid #ccc; text-align:left; background-color:#fff; ">III</td><td class="wp2s2fg_fetcher_table_td " style="font-size:16px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1px solid #ccc; text-align:left; background-color:#fff; ">Iberdomide</td><td class="wp2s2fg_fetcher_table_td " style="font-size:16px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1px solid #ccc; text-align:left; background-color:#fff; ">Lenalidomide </td><td class="wp2s2fg_fetcher_table_td " style="font-size:16px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1px solid #ccc; text-align:left; background-color:#fff; ">7</td><td class="wp2s2fg_fetcher_table_td " style="font-size:16px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1px solid #ccc; text-align:left; background-color:#fff; ">2</td><td class="wp2s2fg_fetcher_table_td " style="font-size:16px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1px solid #ccc; text-align:left; background-color:#fff; "></td><td class="wp2s2fg_fetcher_table_td " style="font-size:16px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1px solid #ccc; text-align:left; background-color:#fff; "></td><td class="wp2s2fg_fetcher_table_td " style="font-size:16px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1px solid #ccc; text-align:left; background-color:#fff; ">曾睦捷/4620</td></tr><tr class="wp2s2fg_fetcher_table_tr"><td class="wp2s2fg_fetcher_table_td " style="font-size:16px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1px solid #ccc; text-align:left; background-color:#fff; ">DREAMM-10(214828)</td><td class="wp2s2fg_fetcher_table_td " style="font-size:16px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1px solid #ccc; text-align:left; background-color:#fff; ">MM</td><td class="wp2s2fg_fetcher_table_td " style="font-size:16px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1px solid #ccc; text-align:left; background-color:#fff; ">1. Newly diagnosed MM
2. ineligible for ASCT</td><td class="wp2s2fg_fetcher_table_td " style="font-size:16px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1px solid #ccc; text-align:left; background-color:#fff; ">BCMA</td><td class="wp2s2fg_fetcher_table_td " style="font-size:16px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1px solid #ccc; text-align:left; background-color:#fff; ">III</td><td class="wp2s2fg_fetcher_table_td " style="font-size:16px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1px solid #ccc; text-align:left; background-color:#fff; ">belantamab mafodotin+Lena+Dexa</td><td class="wp2s2fg_fetcher_table_td " style="font-size:16px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1px solid #ccc; text-align:left; background-color:#fff; ">DRd</td><td class="wp2s2fg_fetcher_table_td " style="font-size:16px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1px solid #ccc; text-align:left; background-color:#fff; ">5</td><td class="wp2s2fg_fetcher_table_td " style="font-size:16px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1px solid #ccc; text-align:left; background-color:#fff; ">3</td><td class="wp2s2fg_fetcher_table_td " style="font-size:16px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1px solid #ccc; text-align:left; background-color:#fff; ">1</td><td class="wp2s2fg_fetcher_table_td " style="font-size:16px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1px solid #ccc; text-align:left; background-color:#fff; ">3</td><td class="wp2s2fg_fetcher_table_td " style="font-size:16px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1px solid #ccc; text-align:left; background-color:#fff; ">鄭采涵/3974</td></tr><tr class="wp2s2fg_fetcher_table_tr"><td class="wp2s2fg_fetcher_table_td " style="font-size:16px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1px solid #ccc; text-align:left; background-color:#fff; ">C1071005 
   </td><td class="wp2s2fg_fetcher_table_td " style="font-size:16px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1px solid #ccc; text-align:left; background-color:#fff; ">MM</td><td class="wp2s2fg_fetcher_table_td " style="font-size:16px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1px solid #ccc; text-align:left; background-color:#fff; ">≥2 prior Tx (Including Lenalidomide and Proteasome Inhibitor )</td><td class="wp2s2fg_fetcher_table_td " style="font-size:16px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1px solid #ccc; text-align:left; background-color:#fff; "> BCMA-Bite</td><td class="wp2s2fg_fetcher_table_td " style="font-size:16px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1px solid #ccc; text-align:left; background-color:#fff; ">III</td><td class="wp2s2fg_fetcher_table_td " style="font-size:16px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1px solid #ccc; text-align:left; background-color:#fff; ">1. Elranatamab
2. Elranatamab+Dara</td><td class="wp2s2fg_fetcher_table_td " style="font-size:16px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1px solid #ccc; text-align:left; background-color:#fff; "></td><td class="wp2s2fg_fetcher_table_td " style="font-size:16px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1px solid #ccc; text-align:left; background-color:#fff; ">10</td><td class="wp2s2fg_fetcher_table_td " style="font-size:16px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1px solid #ccc; text-align:left; background-color:#fff; ">3</td><td class="wp2s2fg_fetcher_table_td " style="font-size:16px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1px solid #ccc; text-align:left; background-color:#fff; "></td><td class="wp2s2fg_fetcher_table_td " style="font-size:16px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1px solid #ccc; text-align:left; background-color:#fff; "></td><td class="wp2s2fg_fetcher_table_td " style="font-size:16px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1px solid #ccc; text-align:left; background-color:#fff; ">曾睦捷/4620</td></tbody></tr><tfoot class="wp2s2fg_fetcher_table_tfoot"><tr class="wp2s2fg_fetcher_table_tr"><td class="wp2s2fg_fetcher_table_td " style="font-size:16px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1px solid #ccc; text-align:left; background-color:#fff; ">87562761MMY1001</td><td class="wp2s2fg_fetcher_table_td " style="font-size:16px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1px solid #ccc; text-align:left; background-color:#fff; ">MM</td><td class="wp2s2fg_fetcher_table_td " style="font-size:16px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1px solid #ccc; text-align:left; background-color:#fff; ">RRMM</td><td class="wp2s2fg_fetcher_table_td " style="font-size:16px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1px solid #ccc; text-align:left; background-color:#fff; ">GPRC5D</td><td class="wp2s2fg_fetcher_table_td " style="font-size:16px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1px solid #ccc; text-align:left; background-color:#fff; ">I</td><td class="wp2s2fg_fetcher_table_td " style="font-size:16px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1px solid #ccc; text-align:left; background-color:#fff; ">JNJ-87562761</td><td class="wp2s2fg_fetcher_table_td " style="font-size:16px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1px solid #ccc; text-align:left; background-color:#fff; "></td><td class="wp2s2fg_fetcher_table_td " style="font-size:16px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1px solid #ccc; text-align:left; background-color:#fff; ">1</td><td class="wp2s2fg_fetcher_table_td " style="font-size:16px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1px solid #ccc; text-align:left; background-color:#fff; ">1</td><td class="wp2s2fg_fetcher_table_td " style="font-size:16px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1px solid #ccc; text-align:left; background-color:#fff; "></td><td class="wp2s2fg_fetcher_table_td " style="font-size:16px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1px solid #ccc; text-align:left; background-color:#fff; "></td><td class="wp2s2fg_fetcher_table_td " style="font-size:16px; color:inherit; line-height:1; letter-spacing:1px; font-weight:normal; border:none; border: 1px solid #ccc; text-align:left; background-color:#fff; ">曾睦捷/4620</td></tfoot></tr></table></div>


<p></p>
        	
        	        </div>

        <div class="clearfix"></div>  

                    <ul class="list-inline">
            	            </ul>
             

        <div class="comment-form">
                    </div>

		<div class="entry-footer">
					</div><!-- .entry-footer -->
	</div>
</article>	

									</div>
				
			</div><!-- row -->
		</div><!-- container -->
	</section><!-- section -->
	
<!--
  ______          _
 |  ____|        | |
 | |__ ___   ___ | |_ ___ _ __
 |  __/ _ \ / _ \| __/ _ \ '__|
 | | | (_) | (_) | ||  __/ |
 |_|  \___/ \___/ \__\___|_|

-->

<footer>
    <div class="container">
        <div class="row">
		 <div class="col-sm-12">
            			</div>
        </div>
    </div>

    <!-- Copyright -->

    <section class="copyright">
        <div class="container">
            <div class="row">
                <div class="col-sm-3">
                    <h6>
                        &copy; 2018. Your Company. All Rights Reserved.                        
                    </h6>
                </div>

                    <div class="col-sm-6">
                        <h6>
                        <a href="https://wordpress.org">Proudly powered by WordPress</a> | Theme: <a href="https://spicethemes.com" rel="designer">Flatter</a> by SpiceThemes                        </h6>
                    </div>
                <div class="col-sm-3">
                   
                        <ul class="list-inline social-media">
                                                            <li><a href="#"><i class="fa fa-facebook"></i></a></li>
                                                            <li><a href="#"><i class="fa fa-twitter"></i></a></li>
                                                            <li><a href="#"><i class="fa fa-google-plus"></i></a></li>
                                                            <li><a href="#"><i class="fa fa-youtube-play"></i></a></li>
                                                            <li><a href="#"><i class="fa fa-linkedin"></i></a></li>
                                                    </ul>

              
                </div>  <!-- /.end of col-sm-3 -->
            </div>
        </div>
    </section>
</footer>
                
	<script type='text/javascript' src='http://trials.hematology.tw/wp-content/themes/flatter/js/bootstrap.js?ver=1.0.0' id='jquery-bootstrap-js'></script>
<script type='text/javascript' src='http://trials.hematology.tw/wp-content/themes/flatter/js/owl.carousel.js?ver=1.0.0' id='jquery-owl-carousel-js'></script>
<script type='text/javascript' src='http://trials.hematology.tw/wp-content/themes/flatter/js/jquery.smartmenus.js?ver=1.0.0' id='jquery-smartmenus-js'></script>
<script type='text/javascript' src='http://trials.hematology.tw/wp-content/themes/flatter/js/wow.js?ver=1.0.0' id='jquery-wow-js'></script>
<script type='text/javascript' src='http://trials.hematology.tw/wp-content/themes/flatter/js/script.js?ver=1.0.0' id='flatter-script-js'></script>
<script type='text/javascript' src='http://trials.hematology.tw/wp-includes/js/wp-embed.min.js?ver=5.7.14' id='wp-embed-js'></script>

</body>
</html>

<!-- Page cached by LiteSpeed Cache 7.6.2 on 2026-02-13 18:40:17 -->